Diagnocure Inc.

CUR-T

Analysis and Opinions about CUR-T

Signal
Opinion
Expert
TOP PICK
TOP PICK
December 3, 2004
Has a test on the market for bladder testing for cancer. Now working with a US company, Gen-Probe, to develop a prostrate diagnostic test for the US and world markets. Tests are 90% accurate compared to the PSA tests which are only right once out of four times. Have also just announced testing for lung cancer with high accuracy figures.
Show full opinionHide full opinion
Diagnocure Inc. (CUR-T)
December 3, 2004
Has a test on the market for bladder testing for cancer. Now working with a US company, Gen-Probe, to develop a prostrate diagnostic test for the US and world markets. Tests are 90% accurate compared to the PSA tests which are only right once out of four times. Have also just announced testing for lung cancer with high accuracy figures.
Showing 1 to 1 of 1 entries
  • «
  • 1
  • »